HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.
about
Update and new approaches in the treatment of Castleman diseasePatient-reported Outcomes for Multicentric Castleman's Disease in a Randomized, Placebo-controlled Study of Siltuximab.Castleman disease and lymphocytic interstitial pneumonia: a complex diagnostic and management challenge.Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma.Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
P2860
HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
HHV-8-associated multicentric ...... therapy for an orphan disease.
@en
HHV-8-associated multicentric ...... therapy for an orphan disease.
@nl
type
label
HHV-8-associated multicentric ...... therapy for an orphan disease.
@en
HHV-8-associated multicentric ...... therapy for an orphan disease.
@nl
prefLabel
HHV-8-associated multicentric ...... therapy for an orphan disease.
@en
HHV-8-associated multicentric ...... therapy for an orphan disease.
@nl
P2093
P2860
P1433
P1476
HHV-8-associated multicentric ...... therapy for an orphan disease.
@en
P2093
Alina Dulau Florea
Amit Mahipal
Emmanuel Besa
Jaime Caro
Maria M Sbenghe
P2860
P304
145-6; author reply 147-8
P356
10.1634/THEONCOLOGIST.2011-0226
P577
2012-01-01T00:00:00Z